@LiverInt
Account based inUnited Kingdom
About this account
- Account based in
- United Kingdom
- Connected via
- Web
Account-level information from X, not a live location or the device used for a specific post.
We publish high-quality original research in Hepatology / Co-EICs @lucavalenti75 @AghemoAlessio @Alexfornergon / IF=6.0 / RT ≠ endorsment
#LiverTwitter
Joined November 2012
- Tweets2.2K
- Following237
- Followers7.4K
- Likes547
Liver International retweeted
🔥 🆙 to publish this work with @HD3vedi and team regarding the importance of #exercise across all types and stages of steatotic liver disease!
Check it out here:
onlinelibrary.wiley.com/doi/…
Liver International retweeted
You can continue #Anticoagulation when you perform #endoscopicbandligation #ELB for #varices
When Undergoing Endoscopic Variceal Ligation: A Systematic Review and Meta‐Analysis
@LiverInt
🔗onlinelibrary.wiley.com/doi/…
Liver International retweeted
Anticoagulation did 🚫increase the risk of bleeding
With/without anticoagulation during EVL, we found a similar risk of:
1) Overall bleeding
2) Severe bleeding
3) Post-banding ulcer bleeding
#Livertwitter 👉doi.org/10.1111/liv.16188…
Indeed, the practice of anticoagulation is heterogeneous.
We recently summarized the existing studies looking at the safety of anticoagulation in patients undergoing EVL
👉doi.org/10.1111/liv.16188
Anticoagulation did 🚫increase the risk of bleeding
Liver International retweeted
Very excited to have the final paper from my #PhD published #OpenAccess in @LiverInt
While #HCV DAA treatment is highly effective, it is important to understand why a small minority are not cured. We aimed to do this with data from 🇦🇺🇨🇦🇫🇷🇳🇱🇪🇸🇨🇭
onlinelibrary.wiley.com/doi/…
Liver International retweeted
In this @LiverInt study, researchers from #Japan shed light on how #MICOS defects impair #mitochondrial function in #MitochondrialDNAdepletionSyndrome, opening new avenues for genetic testing and therapies.
Learn more: doi.org/10.1111/liv.16148
1/2
⬆️ liver tests may not always indicate a higher risk of serious liver disease
Genetic variants influencing common liver test results (like GGT & bilirubin) don't always correlate with higher cirrhosis risk 🤔
🔓bit.ly/3VgbxO4
#livertwitter
2/2
💡 The clinical impact? Using genetics to interpret LBTs may reduce false positives/negatives, optimize resources, and improve diagnostics
further validation in diverse populations is needed! 🌍🩺
#livertwitter
Liver International retweeted
The number and type of metabolic syndrome traits have important impacts on the risk of CKD and incident ESRD in people with MASLD.
@EScorletti, @Alessan95336031, @LiverInt
Read our recent work here:
onlinelibrary.wiley.com/doi/…
Liver International retweeted
🚨 Out now in @LiverInt:
New scenarios in LT for HCC
👥 Led by a great international team in the field.
@Alexfornergon @goncrespo1 @A_DAlessioMD @DJPinato @ColmeneroJordi @liverunitclinic @hospitalclinic @idibaps @BCLC_group @CHBPaulBrousse @HUReinaSofia
onlinelibrary.wiley.com/doi/…
Liver International retweeted
G-CSF is not inferior to corticosteroids in improving 90-day overall survival and 6-months transplant free survival in patients with severe alcohol-associated hepatitis.
Singh et Al @LiverInt
onlinelibrary.wiley.com/doi/…
#livertwitter #GITwitter
Liver International retweeted
Our latest review on the impact of #PNPLA3 variants on clinical outcomes in #MASLD is out in @LiverInt open access @salvatore_petta @lucavalenti75 @stefano_romeo76
onlinelibrary.wiley.com/doi/… – at Turin, Piedmont
Liver International retweeted
🚨 New Research Alert! 🚨
Latest paper in @LiverInt by the @OhioStateSurg TEAM explores the impact of #GLP1RA on adverse liver outcomes among patients with #Alcohol associated #liver disease and type 2 #diabetes
Link 👉 doi.org/10.1111/liv.16132
💡Key finding
GLP-1RA = ⬇️ incidence of adverse liver outcome particularly #hepatic #decompensation
@timpawlik #MedTwitter @ProjectImg
Liver International retweeted
🔴Our work about the burden of hepatitis D in the context of reflex testing has received over 500 views since publication!
📃Read it here onlinelibrary.wiley.com/doi/… #ViewsMilestone
@Mariabutif @AEEHLiver @LiverInt
Liver International retweeted
What a news from @LiverInt! 🥳
Our review on CARVEDILOL IN PORTAL HYPERTENSION has received over 20,000 views since publication! 🥰
@ReibergerThomas @VincenzoLaMura @GiovanniVitale
🔽 onlinelibrary.wiley.com/doi/… #ViewsMilestone
Liver International retweeted
Necesidades no cubiertas en pacientes con hepatitis autoinmune (y son unas cuantas):
👉 Solo el 62% de los pacientes logran respuesta completa tras 1 año de tto
⚠️ Apenas el 27% lo consigue sin esteroides
🔄 30% de los pacientes cambian de tratamiento por intolerancia o no respuesta
📉 Heterogeneidad extrema en los tratamientos entre centros
❌ Necesitamos más alternativas terapéuticas efectivas y seguras
🔓 doi.org/10.1111/liv.16035 en @LiverInt
Detalle relevante: tampoco debería sorprendernos, el tto estándar tiene 50 años!
#livertwitter #HAI
Liver International retweeted
🚨#livertwitter
#Hepatitis #HCV #Elimination
🇦🇹 Austrian #HCV Elimination Project
supported @GileadSciences
5695 #HCV patients screened
397 started on #Antivirals #DAA
326 #HCV patients cured #SVR
✅ #HepC Cure 😇 Survival Benefit
📕@LiverInt
🔗t.ly/UFbQ6
Liver International retweeted
New insights into liver fibrosis in @LiverInt! SHG/TPEF microscopy with #AI offers precise assessment of #fibrosis in MASH F3 patients, revealing changes even when standard scoring shows 'no change.' #livertwitter @DavidKleiner12 bit.ly/3Tyu8nG
ALT Cover of Liver International journal, Volume 40, Number 11, November 2020, featuring an anatomical illustration of a human liver in red overlaying a transparent outline of the human digestive system, against a dark blue background. The cover includes text about the journal's topics such as unhealthy lifestyle and fatty liver, sarcopenia in liver disease, and PBC management update.
Liver International retweeted
“The Liver would be better”
The story behind Neruda’s ode to the liver by @MarcoArreseMD in @LiverInt
onlinelibrary.wiley.com/doi/…
Liver International retweeted
Just recently published at @LiverInt , our work on waitlist outcomes and post-transplant outcomes in MASLD/AIH.
We found better waitlist outcomes on MASLD/AIH compared to MASLD and AIH. No differences on post-LT outcomes.@BonderAlan @HD3vedi @AnaMarencoMD
onlinelibrary.wiley.com/shar…
1/2
A multicenter 🇪🇸 study shows that #Rituximab is a safe & effective option for patients with refractory autoimmune hepatitis
It achieved complete biochemical response in 89% of cases, ⬇️ need for immunosuppressants & corticosteroids
🔓 bit.ly/4ehFh4u
#Livertwitter
2/2
‼️ Despite its efficacy, 31% of patients experienced relapses, successfully managed with additional Rituximab cycles
While promising, prospective studies are needed to validate these findings in advanced #AIH
#livertwitter
